MCFARLAND JOHN (SVP, General Counsel & Sec.) sold 5.5% of their position (884.00 shares) of SYNAPTICS INC on the open market
Open‑market sale worth $93.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/21/2023ACC: 0001209191-23-056395
Officer· SVP, General Counsel & Sec.
Since Oct 2018
-1.13K
Net shares
Net seller
$193.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
698.00 acquired · 1.83K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+698.00
Price / share
—
Trade value
—
% of position
4.3%
11/17/2023
16.32K→17.02K
Common Stock
Direct
Shares
−948.00
Price / share
$105.68
Trade value
$100.18K
% of position
5.6%
11/17/2023
17.02K→16.07K
Common Stock
Direct
Shares
−884.00
Price / share
$105.83
Trade value
$93.56K
% of position
5.5%
11/20/2023
16.07K→15.18K
Total
Net shares
−1.13K
Net value
-$193.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2023 | A · Award | +698.00 | — | — | 4.3% | 16.32K | 17.02K |
| Common Stock Direct | 11/17/2023 | F · Tax Withholding | −948.00 | $105.68 | $100.18K | 5.6% | 17.02K | 16.07K |
| Common Stock Direct | 11/20/2023 | S · Sale | −884.00 | $105.83 | $93.56K | 5.5% | 16.07K | 15.18K |
| Total | −1.13K | -$193.74K | ||||||
Derivative Transactions0
No derivative transactions reported